agilon health (AGL) Competitors

agilon health (NYSE:AGL) and Progyny (NASDAQ:PGNY) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability.

Which has more volatility and risk, AGL or PGNY?

agilon health has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, Progyny has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.

Do insiders and institutionals hold more shares of AGL or PGNY?

94.9% of Progyny shares are held by institutional investors. 3.2% of agilon health shares are held by insiders. Comparatively, 12.3% of Progyny shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has higher valuation and earnings, AGL or PGNY?

Progyny has lower revenue, but higher earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
agilon health	$5.59B	0.12	-$262.60M	-$0.94	-1.79
Progyny	$1.09B	1.09	$62.04M	$0.58	24.10

Is AGL or PGNY more profitable?

Progyny has a net margin of 5.03% compared to agilon health's net margin of -6.88%. Progyny's return on equity of 11.36% beat agilon health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
agilon health	-6.88%	-47.84%	-14.97%
Progyny	5.03%	11.36%	7.87%

Does the MarketBeat Community favor AGL or PGNY?

Progyny received 48 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 71.94% of users gave Progyny an outperform vote while only 47.27% of users gave agilon health an outperform vote.

Company	Underperform	Outperform
agilon health	Outperform Votes 52 47.27%	Underperform Votes 58 52.73%
Progyny	Outperform Votes 100 71.94%	Underperform Votes 39 28.06%

Do analysts prefer AGL or PGNY?

agilon health presently has a consensus price target of $6.05, suggesting a potential upside of 260.12%. Progyny has a consensus price target of $25.42, suggesting a potential upside of 81.81%. Given agilon health's higher probable upside, equities research analysts clearly believe agilon health is more favorable than Progyny.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
agilon health	3 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.95
Progyny	0 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Does the media favor AGL or PGNY?

In the previous week, Progyny had 3 more articles in the media than agilon health. MarketBeat recorded 18 mentions for Progyny and 15 mentions for agilon health. Progyny's average media sentiment score of -0.05 beat agilon health's score of -0.36 indicating that Progyny is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
agilon health	1 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
Progyny	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	7 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Progyny beats agilon health on 16 of the 18 factors compared between the two stocks.